Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment.
Alanood S AlmurshediHessah A AljunaidelBushra T ALquadeibBasmah N AldosariIman M AlfagihSalma S AlmarshidyEram K D EltahirAmany Z MohamoudPublished in: International journal of nanomedicine (2021)
Novel inhalable CIP NCMP powders are a potential new approach to improved target ability and delivery of CIP for NCFB treatment.